Literature DB >> 12429294

Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangrene.

Alan A Nisbet1, Ian M Thompson.   

Abstract

OBJECTIVES: To evaluate, in a population of patients with very high risk of diabetes, the natural history of Fournier's gangrene (FG) and to characterize the differences in presentation and outcome.
METHODS: Patients with FG were identified during a 6-year period at two tertiary care institutions in San Antonio, Texas. The impact of diabetes on presentation and outcome were evaluated and compared with previous series.
RESULTS: We identified 26 patients with FG, of whom 20 (76.9%) had diabetes. Diabetes was the most common risk factor identified and was associated with a younger age. The average hospital stay was not affected by the diagnosis of diabetes. Of 26 patients treated for FG, 3 (11%) died, 1 of whom had diabetes. Although the extent of debridement required was greater among diabetics, the average number of debridements required was not increased (2.55 in diabetic and 2.4 in nondiabetic patients).
CONCLUSIONS: Although diabetes is a risk factor for FG, the outcome is not affected by this diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12429294     DOI: 10.1016/s0090-4295(02)01951-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  20 in total

1.  Fournier's ganrene in the HIV era.

Authors:  Peter Ngugi; George Magoha; Paul Nyaga
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

Review 2.  Fournier's gangrene and its emergency management.

Authors:  A Thwaini; A Khan; A Malik; J Cherian; J Barua; I Shergill; K Mammen
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

3.  [Extensive Fournier gangrene. A dermatologic emergency].

Authors:  R Aschoff; A Baldauf; S Leike; M P Wirth; M Meurer
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

Review 4.  Rectal cancer and Fournier's gangrene - current knowledge and therapeutic options.

Authors:  Tomislav Bruketa; Matea Majerovic; Goran Augustin
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

5.  Outcomes of patients with Fournier's Gangrene: 12-year experience from a tertiary care referral center.

Authors:  Gaurav Garg; Vishwajeet Singh; Rahul Janak Sinha; Ashish Sharma; Siddharth Pandey; Ajay Aggarwal
Journal:  Turk J Urol       Date:  2019-12-01

6.  Prognostic factors and treatment outcomes for patients with Fournier's gangrene: a retrospective study.

Authors:  Kyung Sook Hong; Hee Jung Yi; Ryung-Ah Lee; Kwang Ho Kim; Soon Sup Chung
Journal:  Int Wound J       Date:  2017-09-25       Impact factor: 3.315

7.  Fournier Gangrene in Poorly Controlled Type 1 Diabetes.

Authors:  Dileep Satya; Muneer A Malik; Rakesh Kumar; Devi Dayal; Jaivinder Yadav
Journal:  Indian J Pediatr       Date:  2019-10-16       Impact factor: 1.967

8.  Fournier's gangrene: risk factors and strategies for management.

Authors:  Hakan Yanar; Korhan Taviloglu; Cemalettin Ertekin; Recep Guloglu; Unal Zorba; Neslihan Cabioglu; Irfan Baspinar
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

Review 9.  Solitary Candida albicans Infection Causing Fournier Gangrene and Review of Fungal Etiologies.

Authors:  Tiffany A Perkins; Jared M Bieniek; Joel M Sumfest
Journal:  Rev Urol       Date:  2014

10.  Analysis of prognostic factors affecting mortality in Fournier's gangrene: A study of 72 cases.

Authors:  Mohamed Tarchouli; Ahmed Bounaim; Mohamed Essarghini; Moulay Brahim Ratbi; Mohamed Said Belhamidi; Abdelhak Bensal; Adil Zemmouri; Abdelmounaim Ait Ali; Khalid Sair
Journal:  Can Urol Assoc J       Date:  2015-11-04       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.